Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Toxicological Sciences

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/toxsci/kfw200PMID 27701120PMCID PMC6093617
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Late sodium current block for drug‐induced long QT syndrome: Results from a prospective clinical trial

  2016influential reference
• A New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay Paradigm

  2016cited by this paper
• An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel.

  2016influential reference
• The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative - Update on progress.

  2016cited by this paper
• Electrical Stimulation Promotes Cardiac Differentiation of Human Induced Pluripotent Stem Cells

  2015cited by this paper
• Improvement of acquisition and analysis methods in multi-electrode array experiments with iPS cell-derived cardiomyocytes.

  2015cited by this paper
• A New System for Profiling Drug-Induced Calcium Signal Perturbation in Human Embryonic Stem Cell–Derived Cardiomyocytes

  2015influential reference
• A Non-invasive Platform for Functional Characterization of Stem-Cell-Derived Cardiomyocytes with Applications in Cardiotoxicity Testing

  2015influential reference
• Differentiating Drug‐Induced Multichannel Block on the Electrocardiogram: Randomized Study of Dofetilide, Quinidine, Ranolazine, and Verapamil

  2014influential reference
• International Conference on Harmonisation

  2014cited by this paper
• Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium.

  2014cited by this paper
• Screening for Acute IKr Block Is Insufficient to Detect Torsades de Pointes Liability: Role of Late Sodium Current

  2014cited by this paper
• High-throughput multi-parameter profiling of electrophysiological drug effects in human embryonic stem cell derived cardiomyocytes using multi-electrode arrays.

  2014cited by this paper
• Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.

  2014cited by this paper
• Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes.

  2013cited by this paper
• Induced Pluripotent Stem Cell–Derived Cardiomyocytes: Boutique Science or Valuable Arrhythmia Model?

  2013cited by this paper
• Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model.

  2013cited by this paper
• MICE Models: Superior to the HERG Model in Predicting Torsade de Pointes

  2013cited by this paper
• Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays

  2013cited by this paper
• Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays.

  2013cited by this paper
• Dealing with Global Safety Issues

  2013cited by this paper
• High Risk of QT Interval Prolongation and Torsades de Pointes Associated with Intravenous Quinidine Used for Treatment of Resistant Malaria or Babesiosis

  2012cited by this paper
• Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias

  2012cited by this paper
• Suppression of Phosphoinositide 3-Kinase Signaling and Alteration of Multiple Ion Currents in Drug-Induced Long QT Syndrome

  2012cited by this paper
• Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming.

  2012cited by this paper
• Population Pharmacokinetic and Concentration—QTc Models for Moxifloxacin: Pooled Analysis of 20 Thorough QT Studies

  2011cited by this paper
• High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.

  2011cited by this paper
• Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes.

  2011cited by this paper
• Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines.

  2011cited by this paper
• Non-Cardiomyocytes Influence the Electrophysiological Maturation of Human Embryonic Stem Cell-Derived Cardiomyocytes During Differentiation

  2010cited by this paper
• Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population

  2008cited by this paper
• Late dofetilide-associated life-threatening proarrhythmia.

  2008cited by this paper
• Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

  2007cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Pentamidine-Induced Long QT Syndrome and Block of hERG Trafficking

  2005cited by this paper
• International Conference on Harmonisation; guidance on S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals; availability. Notice.

  2005cited by this paper
• Marked QT Prolongation and Torsades de Pointes Secondary to Acute Ischemia in an Elderly Man Taking Dofetilide for Atrial Fibrillation: A Cautionary Tale

  2005cited by this paper
• Atypical Proarrhythmia with Dofetilide: Monomorphic VT and Exercise‐Induced Torsade de Pointes

  2005cited by this paper
• International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice.

  2005cited by this paper
• Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties

  2004cited by this paper
• Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.

  2004cited by this paper
• Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development.

  2003cited by this paper
• The Duration of Systole in an Electrocardiogram in Normal Humans and in Patients with Heart Disease *

  2003cited by this paper
• Description of a nonselective cation current in human atrium.

  1995influential reference
• A new perspective.

  1988cited by this paper
• Comparative electrophysiologic effects of intravenous amiodarone and desethylamiodarone in dogs: evidence for clinically relevant activity of the metabolite.

  1987cited by this paper

• Stacking Ensemble Machine Learning for Cardiac Safety Assessment Using hiPSC-CM MEA Data.

  2026cites this paper
• Personalized In Vitro Models Reveal Functional Impact of a KCNH2 Mutation and Enable Drug Screening in LQT2

  2026cites this paper
• Paired single-cell imaging of calcium and expression to map niches of identity and function

  2026cites this paper
• AI-Enabled Reduction of Animal Use in Cardiovascular Translational Medicine: Regulatory and Technological Perspectives

  2025cites this paper
• Transformative Potential of Induced Pluripotent Stem Cells in Congenital Heart Disease Research and Treatment

  2025cites this paper
• Delayed Repolarization Caused by hERG Block With Different Drug Modalities Can Be Detected in Stem Cell‐Derived Cardiomyocytes: Incubation Time Matters

  2025cites this paper
• Mechanical and Electrical Phenotype of hiPSC-Cardiomyocytes on Fibronectin-Based Hydrogels.

  2025cites this paper
• Towards human cardiac new approach methodologies (NAMs) to evaluate the combination of repolarization prolonging and shortening drugs: a pilot study

  2025influential citation
• Comprehensive promotion of iPSC-CM maturation by integrating metabolic medium with nanopatterning and electrostimulation

  2025influential citation
• Integrating drug effects on individual cardiac ionic currents and cardiac action potentials to understand nonclinical translation to clinical ECG changes

  2025cites this paper
• Field potential Imaging in human iPSC- derived Cardiomyocytes using UHD-CMOS-MEA

  2025cites this paper
• Engineered ACE2 decoy in dry powder form for inhalation: A novel therapy for SARS-CoV-2 variants

  2025cites this paper
• Reassessing the Conduct of Patch Clamp Cardiac Ion Channel Assays to Improve Nonclinical Data Translation to Clinical ECG Changes and Proarrythmia Risk

  2025influential citation
• DMSO-free cryopreservation of hiPSC-derived cardiomyocytes: low temperature characterization and protocol development

  2025cites this paper
• DMSO-free cryopreservation of hiPSC-derived cardiomyocytes: Low temperature characterization and protocol development

  2025cites this paper
• Developing an approach for evaluating the cardiotoxic potential of botanicals

  2025cites this paper
• Non-clinical cardiovascular safety testing: Current status, gaps and emerging trends.

  2025cites this paper
• Combine the wet and dry ingredients: Mixing experimental and computational models for a deeper understanding of stem cell-derived cardiomyocytes.

  2025cites this paper
• Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillation

  2025cites this paper
• Advanced cardiotoxicity profiling using field potential imaging with UHD-CMOS-MEA in human iPSC-derived cardiomyocytes

  2025cites this paper
• Advantages of long-term evaluation of doxorubicin-induced cardiotoxicity using human iPSC-derived cardiomyocyte sheet tissues with continuous contractile force measurement under constant pacing.

  2025cites this paper
• Improved translation of Nav1.5 channel inhibition to in vivo QRS interval prolongation via the hIPSC cardiomyocyte model.

  2025cites this paper
• CiPA-qualified human iPSC-derived cardiomyocytes: A new frontier in toxicity testing by evaluating drug-induced arrhythmias.

  2025cites this paper
• Bridging the gaps in detection of structural cardiotoxicity in stem cell-derived cardiomyocytes: promise of miR-133b, miR-184 and miR-208b-3p

  2025cites this paper
• Non-invasive maturity assessment of iPSC-CMs based on optical maturity characteristics using interpretable AI

  2025cites this paper
• Cardiovascular safety pharmacology: beyond arrhythmic risk assessment

  2025cites this paper
• Integral approach to organelle profiling in human iPSC-derived cardiomyocytes enhances in vitro cardiac safety classification of known cardiotoxic compounds

  2025cites this paper
• Wave propagation enhances extracellular signal strength in small excitable tissues

  2025cites this paper
• Field potential duration and its variability as essential parameters for revealing proarrhythmia: problematic aspects of analysis in cardiomyocytes derived from human pluripotent stem cells.

  2025cites this paper
• Electrophysiological Changes in the Rabbit Ventricular Wedge and Human-Induced Pluripotent Stem-Cell Derived (IPSC) Cardiomyocytes Translate to Severe Arrhythmia Observed in a Canine Toxicology Study, Not Predicted by Standard In Vitro Ion Channel Assays

  2024cites this paper
• Pathway-based similarity measurement to quantify transcriptomics similarity between human tissues and preclinical models

  2024influential citation
• hiPSC-CM Electrophysiology: Impact of Temporal Changes and Study Parameters on Experimental Reproducibility.

  2024cites this paper
• A versatile high-throughput assay based on 3D ring-shaped cardiac tissues generated from human induced pluripotent stem cell-derived cardiomyocytes

  2024cites this paper
• The electrophysiologic effects of KCNQ1 extend beyond expression of IKs: evidence from genetic and pharmacologic block.

  2024cites this paper
• Non-invasive assessment of proarrhythmic risks associated with isoprenaline and the dietary supplement ingredient synephrine using human induced pluripotent stem cell-derived cardiomyocytes

  2024cites this paper
• iPSC-cardiomyocytes in the preclinical prediction of candidate pharmaceutical toxicity

  2024cites this paper
• Nonclinical evaluation of chronic cardiac contractility modulation on 3D human engineered cardiac tissues

  2024cites this paper
• Human induced pluripotent stem cell-derived closed-loop cardiac tissue for drug assessment

  2024influential citation
• A review of local anesthetic-induced heart toxicity using human induced pluripotent stem cell-derived cardiomyocytes.

  2024cites this paper
• Using induced pluripotent stem cells for drug discovery in arrhythmias

  2024cites this paper
• Bayesian approach enabled objective comparison of multiple human iPSC-derived Cardiomyocytes' Proarrhythmia sensitivities.

  2024cites this paper
• Comparative cardiotoxicity assessment of bisphenol chemicals and estradiol using human induced pluripotent stem cell-derived cardiomyocytes.

  2024cites this paper
• Dual effects of mefenamic acid on the IKs molecular complex

  2024cites this paper
• Engineered tissue geometry and Plakophilin-2 regulate electrophysiology of human iPSC-derived cardiomyocytes

  2024cites this paper
• Evaluation of the cardiotoxicity of Echinochrome A using human induced pluripotent stem cell-derived cardiac organoids.

  2024cites this paper
• Promising tools for future drug discovery and development in antiarrhythmic therapy.

  2024cites this paper
• Contractility assessment using aligned human iPSC-derived cardiomyocytes.

  2024cites this paper
• FRESH™ 3D Bioprinted Cardiac Tissue, a Bioengineered Platform for in vitro Toxicology and Pharmacology

  2023cites this paper
• The three-dimensionality of the hiPSC-CM spheroid contributes to the variability of the field potential

  2023cites this paper
• The evolving role of investigative toxicology in the pharmaceutical industry

  2023cites this paper
• Bayesian Approach Enabled Objective Comparison of Multiple Human iPSC-derived Cardiomyocytes’ Proarrhythmia Sensitivities

  2023cites this paper
• Precision medicine for long QT syndrome: patient-specific iPSCs take the lead

  2023cites this paper
• New science, drug regulation, and emergent public health issues: The work of FDA’s division of applied regulatory science

  2023cites this paper
• FRESH™ 3D bioprinted cardiac tissue, a bioengineered platform for in vitro pharmacology

  2023cites this paper
• CRISPRi Gene Modulation and All-Optical Electrophysiology in Post-Differentiated Human iPSC-Cardiomyocytes

  2023cites this paper
• iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development

  2023cites this paper
• 4D Thermo-Responsive Smart hiPSC-CM Cardiac Construct for Myocardial Cell Therapy

  2023cites this paper
• Advances in the design, generation, and application of tissue-engineered myocardial equivalents

  2023cites this paper
• The Potential Mechanisms behind Loperamide-Induced Cardiac Arrhythmias Associated with Human Abuse and Extreme Overdose

  2023influential citation
• An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models

  2023cites this paper
• OptoDyCE-plate as an affordable high throughput imager for all optical cardiac electrophysiology

  2023cites this paper
• The impact of genetics on the long QT syndrome: myth or reality?

  2023cites this paper
• hiPSC-CM Electrophysiology: Impact of Temporal Changes and Study Parameters on Experimental Reproducibility

  2023cites this paper
• An engineered ACE2 decoy broadly neutralizes Omicron subvariants and shows therapeutic effect in SARS-CoV-2-infected cynomolgus macaques

  2023cites this paper
• Pro-arrhythmic effect of escitalopram and citalopram at serum concentrations commonly observed in older patients – a study based on a cohort of 19,742 patients

  2023cites this paper
• Biotechnological advances and applications of human pluripotent stem cell-derived heart models

  2023cites this paper
• High-throughput longitudinal electrophysiology screening of mature chamber-specific hiPSC-CMs using optical mapping

  2023cites this paper
• New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models

  2023cites this paper
• Comparative cardiotoxicity assessment of bisphenol chemicals and estradiol using human induced pluripotent stem cell-derived cardiomyocytes

  2023cites this paper
• CRISPRi gene modulation and all-optical electrophysiology in post-differentiated human iPSC-cardiomyocytes

  2023cites this paper
• Enhancing the functional maturity of hiPSC-derived cardiomyocytes to assess inotropic compounds.

  2023cites this paper
• [Toward Regulatory Acceptance of MPS-Cardiac Safety Assessment as an Example].

  2023cites this paper
• Bioprinted in vitro tissue models: an emerging platform for developing therapeutic interventions and disease modelling

  2023cites this paper
• Lower cardiotoxicity of CPX-351 relative to daunorubicin plus cytarabine free-drug combination in hiPSC-derived cardiomyocytes in vitro

  2023cites this paper
• Microfluidic Organ-Chips and Stem Cell Models in the Fight Against COVID-19

  2023cites this paper
• Long-term in vitro recording of cardiac action potentials on microelectrode arrays for chronic cardiotoxicity assessment

  2023cites this paper
• Chronic Prestress Regulation of Micro-Heart Muscle Physiology

  2023cites this paper
• Detecting and measuring of GPCR signaling – comparison of human induced pluripotent stem cells and immortal cell lines

  2023cites this paper
• Human-Induced Pluripotent Stem Cell-Based Differentiation of Cardiomyocyte Subtypes for Drug Discovery and Cell Therapy.

  2023cites this paper
• A Bioprinted Heart-on-a-Chip with Human Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Evaluation

  2022cites this paper
• Simultaneous measurement of contraction forces and field potentials of cardiomyocytes subjected to ion channel inhibitors

  2022cites this paper
• Investigating the effect of Shenmai injection on cardiac electrophysiology and calcium signaling using human-induced pluripotent stem cell-derived cardiomyocytes

  2022cites this paper
• A tiered approach to population-based in vitro testing for cardiotoxicity: Balancing estimates of potency and variability.

  2022cites this paper
• Xeno-Free Integrated Platform for Robust Production of Cardiomyocyte Sheets from hiPSCs

  2022cites this paper
• Prediction of inotropic effect based on calcium transients in human iPSC-derived cardiomyocytes and machine learning.

  2022cites this paper
• Acute effects of cardiac contractility modulation stimulation in conventional 2D and 3D human induced pluripotent stem cell-derived cardiomyocyte models

  2022cites this paper
• Human cardiomyocytes are more susceptible to irreversible electroporation by pulsed electric field than human esophageal cells

  2022cites this paper
• Functional human cell-based vascularised cardiac tissue model for biomedical research and testing

  2022cites this paper
• Validating the Arrhythmogenic Potential of High-, Intermediate-, and Low-Risk Drugs in a Human-Induced Pluripotent Stem Cell-Derived Cardiac Microphysiological System.

  2022cites this paper
• Repeated and On-Demand Intracellular Recordings of Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells

  2022cites this paper
• Beyond Pharmaceuticals: Fit-for-Purpose New Approach Methodologies for Environmental Cardiotoxicity Testing

  2022cites this paper
• Downregulation of hERG Channel Expression By Tyrosine Kinase Inhibitors Nilotinib And Vandetanib Predominantly Contributes To Arrhythmogenesis.

  2022cites this paper
• Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)

  2022cites this paper
• Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neurons.

  2022cites this paper
• Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

  2022cites this paper
• The Challenges of Predicting Drug-Induced QTc Prolongation in Humans

  2022cites this paper
• Scalable expansion of iPSC and their derivatives across multiple lineages.

  2022cites this paper
• Predicting human cardiac QT alterations and pro-arrhythmic effects of compounds with a 3D beating heart-on-chip platform

  2022cites this paper
• Transcriptional co‐activators YAP1–TAZ of Hippo signalling in doxorubicin‐induced cardiomyopathy

  2021cites this paper
• Cardiovascular Safety Assessment in Cancer Drug Development

  2021cites this paper